1. Home
  2. APM vs SPHL Comparison

APM vs SPHL Comparison

Compare APM & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$0.84

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$2.60

Market Cap

6.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
APM
SPHL
Founded
2010
2002
Country
United Kingdom
Singapore
Employees
N/A
71
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
6.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
APM
SPHL
Price
$0.84
$2.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.7K
6.7K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.35
52 Week High
$4.47
$25.11

Technical Indicators

Market Signals
Indicator
APM
SPHL
Relative Strength Index (RSI) 41.99 48.30
Support Level $0.75 $2.46
Resistance Level $0.86 $2.74
Average True Range (ATR) 0.06 0.21
MACD -0.00 -0.00
Stochastic Oscillator 14.93 16.67

Price Performance

Historical Comparison
APM
SPHL

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: